FDA
-
-
-
-
-
-
-
Blue Water Vaccines (BWV) CEO Issues Letter to Shareholders
-
-
-
-
-
-
-
Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds
-
-
-
-
-
-
-
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products
-
-
-
-
-
-
-
Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas
-
-
-
-
-
-
-
Blue Water Vaccines (BWV) Announces Acquisition of ENTADFI, an FDA-Approved Benign Prostatic Hyperplasia Asset
-
-
-
-
-
-
-
Blue Water Vaccines (BWV) Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates
-
-
-
-
-
-
-
Blue Water Vaccines (BWV) Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

